In 2025, the Asia-Pacific (APAC) region will emerge as the global growth engine for biotechnology and life sciences. While North America and Europe continue to experience a “biotech winter” — marked by funding cuts, layoffs, and investor caution — APAC’s market is expanding rapidly. Fueled by government investment, multinational risk diversification, and the integration of … APAC vs. The West: The Biotech Power Shift is Real. Navigating Asia-Pacific’s Ascent as the Global Life Science Engine Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.